SBIR-STTR Award

Development Of A Novel Assay For Protease Inhibitors
Award last edited on: 7/26/13

Sponsored Program
SBIR
Awarding Agency
NIH : NIGMS
Total Award Amount
$94,102
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Shaojie Wang

Company Information

Morphochem Inc (AKA: SMALL MOLECULE THERAPEUTICS, INC)

11 Deer Park Drive Suite 116
Monmouth Junction, NJ 08852
   (732) 274-2882
   N/A
   N/A
Location: Single
Congr. District: 12
County: Middlesx

Phase I

Contract Number: 1R43GM060086-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1999
Phase I Amount
$94,102
The U.S. Army has long recognized the potential of composite materials as a structural and ballistic armor material to realize weight reductions while maintaining appropriate levels of structural integrity and ballistic protection. Current ceramic armor multi-hit performance is below full potential due to excessive crack propagation from projectile impacts. Recent advancements in Ceramic Matrix Composite (CMC) materials may offer a solution to the relative fragility of monolithic composites. CMC's are highly flexible in their total composition, allowing considerable options for additives, coatings and laminations, compared to monolithic ceramics. We propose to develop an integrated, lightweight composite ballistic skirt for ground vehicle applications. The materials and techniques developed under the effort will be directly applicable to the design and integration of composite ballistic fenders as an inherent project objective. In Phase I, we will define the ceramic material requirements and specifications, identify alternative skirt design concepts and integration approaches. This effort will include threat definition, system and material requirements, the identification of available data on the ballistic and structural performance of the recommended ceramic material, the establishment of material specifications and development of a feasibility prototype skirt panel section design concept.

Benefits:
Development of lightweight structural composite materials, processe.

Thesaurus Terms:
Bioassay, Gene Complementation, Protease Inhibitor, Technology /Technique Development Beta Galactosidase, Chimeric Protein, Cytomegalovirus, Enzyme Mechanism, Enzyme Substrate, Virus Protein Tissue /Cell Culture, Western Blotting

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----